BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• 

  BioCapital

  Alnylam’s “Incredibly Deep” Pipeline Continues to Impress As Commercial Stage Looms, Says Analyst

  February 27, 2015

   · 

  2 min read
• 

  Drug Development

  Gilead’s Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C and HIV

  February 27, 2015

   · 

  6 min read
• 

  Policy

  Novartis AG Japan Ordered to Halt Business for 15 Days

  February 27, 2015

   · 

  2 min read
• Genetown

  First World War Explosive Could Reverse Diabetes, Yale University Study

  February 27, 2015

   · 

  2 min read
• Biotech Bay

  Gilead Holds Cash Overseas to Save Billions on Taxes

  February 27, 2015

   · 

  1 min read
• Early Signs In Kids Predict Type 1 Diabetes, Lund University Study

  February 27, 2015

   · 

  2 min read
• New App Helps Monitor Depression, University of Birmingham Study

  February 27, 2015

   · 

  3 min read
• Urine Test Predicts Heart Failure Patients’ Risk Of Kidney Injury, Southern Medical University Study

  February 27, 2015

   · 

  1 min read
• Pharm Country

  New Peanut Allergy Test Goes Beyond Scratching The Surface, University of Connecticut Study

  February 27, 2015

   · 

  4 min read
• BioCapital

  Decision On Ebola Mass Vaccination In August At Earliest: WHO

  February 27, 2015

   · 

  1 min read